BiomX Inc. (PHGE-UN)

USD 0.9

(-5.26%)

Inventory Summary of BiomX Inc.

  • BiomX Inc.'s latest annual inventory in 2023 was - USD , down -100.0% from previous year.
  • BiomX Inc.'s latest quarterly inventory in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • BiomX Inc. reported annual inventory of 395 Thousand USD in 2022, up 265.74% from previous year.
  • BiomX Inc. reported annual inventory of 108 Thousand USD in 2021, down 0.0% from previous year.
  • BiomX Inc. reported quarterly inventory of - USD for 2024 Q1, down 0.0% from previous quarter.
  • BiomX Inc. reported quarterly inventory of - USD for 2023 FY, down -100.0% from previous quarter.

Annual Inventory Chart of BiomX Inc. (2023 - 2017)

Historical Annual Inventory of BiomX Inc. (2023 - 2017)

Year Inventory Inventory Growth
2023 - USD -100.0%
2022 395 Thousand USD 265.74%
2021 108 Thousand USD 0.0%
2020 - USD -100.0%
2019 1.97 Million USD 6920.69%
2018 -29 Thousand USD 0.0%
2017 - USD 0.0%

Peer Inventory Comparison of BiomX Inc.

Name Inventory Inventory Difference
AIM ImmunoTech Inc. -1.18 Million USD 100.0%
Ampio Pharmaceuticals, Inc. 1.00 USD 100.0%
Armata Pharmaceuticals, Inc. - USD NaN%
Actinium Pharmaceuticals, Inc. - USD NaN%
Azitra, Inc. -215.21 Thousand USD 100.0%
Can-Fite BioPharma Ltd. - USD NaN%
Chromocell Therapeutics Corporation - USD NaN%
Calidi Biotherapeutics, Inc. - USD NaN%
CEL-SCI Corporation 2.24 Million USD 100.0%
iBio, Inc. - USD NaN%
Lineage Cell Therapeutics, Inc. - USD NaN%
MAIA Biotechnology, Inc. - USD NaN%
Matinas BioPharma Holdings, Inc. - USD NaN%
Navidea Biopharmaceuticals, Inc. 427.34 Thousand USD 100.0%
NovaBay Pharmaceuticals, Inc. 2.87 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
Oragenics, Inc. - USD NaN%
BiomX Inc. - USD NaN%
Protalix BioTherapeutics, Inc. 19.04 Million USD 100.0%
Palatin Technologies, Inc. - USD NaN%
Scorpius Holdings, Inc. 909.15 Thousand USD 100.0%